Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Intensive Program Relieves Symptoms of Juvenile Fibromyalgia

Lara C. Pullen, PhD  |  August 17, 2015

GENERIC_Clinical_500x270Intensive physical therapy (PT), occupational therapy (OT) and psychotherapy can be combined to successfully treat children with fibromyalgia. The treatment can take place without the use of medications and yet still result in significantly reduced pain and improved function. The program, implemented by The Children’s Hospital of Philadelphia (CHOP), is organized around the philosophy that children can heal themselves with tools they learn from therapists.1

David D. Sherry, MD, section chief of the Division of Rheumatology at CHOP, and colleagues describe their therapy approach in The Journal of Pediatrics in an article published on July 21, 2015. Their study included 64 children with a mean age of 16 years. More than 90% of the children were girls who had a mean duration of symptoms of 21 months. The investigators noted that the study was neither randomized nor controlled. Moreover, the therapy program was individualized to each patient, thus, lasting different lengths of time for each patient. In general, the children received five to six hours of intensive PT/OT daily and at least four hours of psychosocial services per week. The mean duration of the program was 23 days, ±13 days. All children were off pain medicine during the therapy program and for their one-year follow-up.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The mean pain score decreased significantly from program entry to program completion (p=0.001). Moreover, at the one-year follow-up appointment, 33% of patients reported no pain. The Bruininks-Oseretsky Test of Motor Performance, Second Edition (BOT-2), revealed that all measures of function improved significantly by the end of the program and either stayed at that level or continued to improve over the course of a year. When the children were given the Bruce treadmill protocol test, their time increased from 588 seconds to 801 seconds (p<0.001) and then decreased to 750 seconds (p=0.005), which represented the 90th percentile for age and sex. The children also experienced significant improvements on the All Pain Stages of Change Questionnaire, Pediatric Quality of Life Inventory and Teen Report total score.

“Our children with long-standing fibromyalgia exhibited significant improvement in nearly all of the functional and pain measures that we applied. Function, as measured by the FDI [functional disability inventory], went from the moderately disabled category to normal and remained normal for the year after program completion. The BOT-2 battery continued to improve significantly over the one-year period,” wrote the authors.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patients not only reported less pain one year after program completion, but they also were able to regain normal function and, in some cases, achieve remission. The authors propose that the intensity of the program was critical to its success.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:FibromyalgiaPainPain Management

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Diagnosing & Caring for Patients with Fibromyalgia

    May 19, 2022

    Doebl et al. compared the effect of symptoms and the healthcare use of people with fibromyalgia with those who fulfilled the criteria for fibromyalgia but had not been diagnosed and those with chronic pain. They found patients diagnosed with fibromyalgia reported the poorest healthcare experiences and were more likely than other study participants to be unemployed due to health issues. Their findings reveal an urgent need exists for a model of care for patients with fibromyalgia.

    Treat-to-Target Strategy Evaluated for Fibromyalgia Care

    September 19, 2017

    Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences